Yoko Tabe, MD, PhD1,2, Shinichi Yamamoto, PhD3*, Mika Kikkawa, PhD4*, Hikari Taka, PhD4*, Kaoru Mogushi, PhD5*, Hiromichi Mastushita, MD, PhD6*, Takashi Miida, MD.PhD7*, Michael Andreeff, MD, PhD8, Paul A Spagnuolo, Ph.D.9 and Marina Konopleva, MD, PhD10
1Section of Molecular Hematology & Therapy, Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston
2Department of Clinical Laboratory Medicine, Juntendo Univerisity School of Medicine, Tokyo, Japan
3Department of Clinical Laboratory Medicine, Juntendo University, Tokyo, Japan
4Laboratory of Proteomics and Biomolecular Science, BioMedical Research Center, Tokyo, Japan
5Center for Genomic and Regenerative Medicine, , Juntendo University Graduate School of Medicine, Tokyo, Japan
6Department of Laboratory Medicine, Tokai University School of Medicine, Tokyo, Japan
7Department of Clinical Laboratory Medicine, Juntendo University School of Medicine, Tokyo, Japan
8Section of Molecular Hematology and Therapy, Leukemia Department, UT MD Anderson Cancer Center, Houston, TX
9School of Pharmacy, University of Waterloo, Waterloo, ON, Canada
10Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX